Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis - Archive ouverte HAL
Article Dans Une Revue PLoS ONE Année : 2009

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis

Sylvie Manin
  • Fonction : Auteur

Résumé

Obesity-associated inflammation is of critical importance in the development of insulin resistance and non-alcoholic fatty liver disease. Since the cannabinoid receptor CB2 regulates innate immunity, the aim of the present study was to investigate its role in obesity-induced inflammation, insulin resistance and fatty liver.

Dates et versions

hal-04496780 , version 1 (08-03-2024)

Identifiants

Citer

Vanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani, Fatima Teixeira-Clerc, Alexandre Louvet, et al.. Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis. PLoS ONE, 2009, 4 (6), pp.e5844. ⟨10.1371/journal.pone.0005844⟩. ⟨hal-04496780⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

More